Wird geladen...
The effects of topiroxostat on vascular function in patients with hyperuricemia
Xanthine oxidoreductase (XOR) inhibitors, such as allopurinol and febuxostat, inhibit the catalysis of serum uric acid (SUA) synthesis. In doing so, they are thought to improve vascular endothelial function in patients with hyperuricemia and cardiovascular risk by reducing increases in SUA and react...
Gespeichert in:
| Veröffentlicht in: | J Clin Hypertens (Greenwich) |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8030428/ https://ncbi.nlm.nih.gov/pubmed/31556223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13707 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|